Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats - Sedlinsky, C; Molinuevo, MS; Cortizo, AM; Tolosa, MJ; Felice, JI; Sbaraglini, ML (Eur J Pharmacol, 2011)
et al.